Savior Lifetec (4167) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Savior Lifetec (4167) has a cash flow conversion efficiency ratio of -0.026x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$-98.65 Million ≈ $-3.11 Million USD) by net assets (NT$3.78 Billion ≈ $119.12 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Savior Lifetec liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Savior Lifetec - Cash Flow Conversion Efficiency Trend (2011–2025)
This chart illustrates how Savior Lifetec's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Savior Lifetec Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Savior Lifetec ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
X-Legend Entertainment Co Ltd
TW:4994
|
0.036x |
|
Eastern Media International Corp
TW:2614
|
0.080x |
|
AMIA Co. Ltd.
TW:8438
|
0.062x |
|
TriSalus Life Sciences Inc.
NASDAQ:TLSI
|
0.139x |
|
AgriFORCE Growing Systems Ltd
NASDAQ:AGRI
|
-0.196x |
|
Inversora Juramento SA
BA:INVJ
|
-0.033x |
|
Deep Value Driller AS
OL:DVD
|
0.957x |
|
Bang & Olufsen
CO:BO
|
0.041x |
Annual Cash Flow Conversion Efficiency for Savior Lifetec (2011–2025)
The table below shows the annual cash flow conversion efficiency of Savior Lifetec from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see 4167 company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | NT$3.78 Billion ≈ $119.12 Million |
NT$-21.04 Million ≈ $-662.91K |
-0.006x | -103.77% |
| 2024-12-31 | NT$3.52 Billion ≈ $110.78 Million |
NT$518.38 Million ≈ $16.33 Million |
0.147x | +27.87% |
| 2023-12-31 | NT$3.36 Billion ≈ $106.01 Million |
NT$387.95 Million ≈ $12.22 Million |
0.115x | -33.27% |
| 2022-12-31 | NT$3.37 Billion ≈ $106.08 Million |
NT$581.77 Million ≈ $18.33 Million |
0.173x | +440.04% |
| 2021-12-31 | NT$3.31 Billion ≈ $104.37 Million |
NT$-168.34 Million ≈ $-5.30 Million |
-0.051x | -285.45% |
| 2020-12-31 | NT$3.33 Billion ≈ $104.92 Million |
NT$91.25 Million ≈ $2.87 Million |
0.027x | -61.21% |
| 2019-12-31 | NT$2.21 Billion ≈ $69.75 Million |
NT$156.40 Million ≈ $4.93 Million |
0.071x | +169.06% |
| 2018-12-31 | NT$1.86 Billion ≈ $58.47 Million |
NT$-189.84 Million ≈ $-5.98 Million |
-0.102x | -184.82% |
| 2017-12-31 | NT$2.16 Billion ≈ $68.15 Million |
NT$260.89 Million ≈ $8.22 Million |
0.121x | +435.93% |
| 2016-12-31 | NT$2.12 Billion ≈ $66.77 Million |
NT$-76.09 Million ≈ $-2.40 Million |
-0.036x | +86.25% |
| 2015-12-31 | NT$1.59 Billion ≈ $50.15 Million |
NT$-415.82 Million ≈ $-13.10 Million |
-0.261x | -265.61% |
| 2014-12-31 | NT$1.29 Billion ≈ $40.75 Million |
NT$-92.41 Million ≈ $-2.91 Million |
-0.071x | -16.66% |
| 2013-12-31 | NT$1.39 Billion ≈ $43.93 Million |
NT$-85.39 Million ≈ $-2.69 Million |
-0.061x | +65.70% |
| 2012-12-31 | NT$1.27 Billion ≈ $40.16 Million |
NT$-227.59 Million ≈ $-7.17 Million |
-0.179x | +48.89% |
| 2011-12-31 | NT$1.31 Billion ≈ $41.38 Million |
NT$-458.82 Million ≈ $-14.46 Million |
-0.349x | -- |
About Savior Lifetec
Savior Lifetec Corporation, a specialty injectable company, develops, produces, and supplies sterile active pharmaceutical ingredients and finished dosage formulations. The company provides various carbapenem generic drugs and injections, such as paliperidone palmitate, cetrorelix and ganirelix acetate, plecanatide, prucalopride succinate, and brinzolamide. It offers imipenem and cilastatin, mero… Read more